Globus Medical Inc Class A GMED

Morningstar Rating
$77.00 −3.91 (4.83%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GMED is trading at a LOCK|&k^Mv premium.
Price
$77.00
Fair Value
LOCK|.t<$$Z%
Uncertainty
LOCK|X>Y
1-Star Price
LOCK|.$@pkLm
5-Star Price
LOCK|.LX>G&VW
Economic Moat
LOCK|^>
Capital Allocation

News

Trading Information

Previous Close Price
$80.91
Day Range
$76.2680.74
52-Week Range
$51.79101.40
Bid/Ask
$76.50 / $83.50
Shares Outstanding
135.74M
Market Cap
$10.45B
Volume/Avg
2M / 2M

Key Statistics

Price/Earnings (Normalized)
17.35
Price/Sales
3.39
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
1.05%

Company Profile

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
6,000

Valuation

Metric
GMED
Price/Earnings (Normalized)
17.35
Price/Book Value
2.21
Price/Sales
3.39
Price/Cash Flow
11.92
Price/Earnings
GMED

Financial Strength

Metric
GMED
Quick Ratio
2.83
Current Ratio
4.56
Interest Coverage
Quick Ratio
GMED

Profitability

Metric
GMED
Return on Assets (Normalized)
11.87%
Return on Equity (Normalized)
13.71%
Return on Invested Capital (Normalized)
13.15%
Return on Assets
GMED

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|Z&%>YwFLOCK|sM!R?$175B
Stryker Corp
SYK
LOCK|?XnVq?tvLOCK|<&$123B
Medtronic PLC
MDT
LOCK|D#H!$>gLOCK|mt@Nr$106B
Boston Scientific Corp
BSX
LOCK|%%Cch@&LOCK|&r%kz$65B
Edwards Lifesciences Corp
EW
LOCK|n&YTM$?sLOCK|r@#C>$49B
DexCom Inc
DXCM
LOCK|Bqf?@JGLOCK|x%frX$30B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|!%^dJhLLOCK|p?$29B
Koninklijke Philips NV ADR
PHG
LOCK|ylMLOCK|p>T$26B
Steris PLC
STE
LOCK|#@#%w?LOCK|>%g#R$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|%@&ZXFtCLOCK|%!S$18B

Sponsor Center